Decoding the Science: The Bacterial Reverse Mutation Test (Ames Test)
OECD Test Guideline 471 (TG 471) is widely regarded as a cornerstone of chemical safety assessment. Formally known as the Bacterial Reverse Mutation Test, it serves as a critical primary screening tool to rapidly and cost-effectively evaluate whether a chemical substance possesses genotoxic potential.
1. The Core of Detection: Hazardous "Point Mutations"
The danger of genotoxicity lies in the permanent damage to genetic material (DNA). The TG 471 assay focuses on detecting a specific type of DNA damage known as point mutations.
Point mutations involve minute changes in the DNA sequence where a single or few base pairs are substituted, added, or deleted. While these changes may seem negligible, research indicates that point mutations are closely linked to many human hereditary diseases and the process of tumorigenesis in somatic cells via oncogenes and tumor suppressor genes.
TG 471 evaluates potential hazards by detecting two primary types of point mutations:
- Base Substitution Mutagens: Agents that alter a specific base pair in the DNA.
- Frameshift Mutagens: Agents that cause the addition or deletion of one or more base pairs, shifting the "reading frame" of the genetic code.
2. Experimental Principle: Restoring "Defective" Bacteria
The test is termed a "Reverse Mutation" assay because its mechanism relies on repairing a pre-existing genetic defect.
The Model Organisms: TG 471 utilizes specially engineered strains of Salmonella typhimurium and Escherichia coli. These are known as auxotrophic strains because they carry mutations that render them unable to synthesize an essential amino acid (such as histidine or tryptophan) required for growth.
The Process of Reversion:
-
The auxotrophic bacterial suspension is exposed to the test chemical.
-
If the substance is mutagenic, it induces further mutations in the bacterial DNA.
-
If a new mutation happens to reverse (revert) the original defect, the bacteria regain the ability to synthesize the essential amino acid.
-
The mixture is then plated on a medium lacking that specific amino acid.
-
Following 48 to 72 hours of incubation, only "revertant" bacteria that have regained their biosynthetic capability can form colonies.
By counting these revertant colonies and comparing them to the spontaneous reversion rate of a solvent control, researchers can determine the mutagenicity of the substance.
To ensure the detection of diverse mutagenic mechanisms, the test must employ at least five different strains. Since many Salmonella strains target GC base pairs, it is recommended to include strains targeting AT base pairs (such as E. coli WP2 or S. typhimurium TA102) to detect certain oxidative mutagens.
3. The Necessity of S9 Mix: Simulating Human Metabolism
A significant challenge in toxicology is that many substances are harmless in their original form but become toxic after being metabolized by the body. Because bacteria (prokaryotes) differ from mammals in absorption, metabolism, and DNA structure, they lack the metabolic machinery to "activate" these chemicals.
To bridge this gap, TG 471 requires testing to be conducted both with and without an exogenous metabolic activation system. The most common system used is the S9 Mix.
-
What is S9? It is a post-mitochondrial fraction derived from rodent livers treated with enzyme inducers (such as Aroclor 1254 or a combination of Phenobarbital and $\beta$-naphthoflavone).
-
The Role of S9: The mix provides metabolic enzymes that allow the test chemical to undergo biotransformation in vitro.
- The Result: This ensures that substances requiring hepatic activation to become mutagenic can be effectively identified.
4. Implementation and Limitations
TG 471 specifies two primary procedures:
- Plate Incorporation Method: Bacterial suspension, test substance, and S9 mix (if applicable) are mixed with overlay agar and poured directly onto minimal medium plates.
- Preincubation Method: The test substance and bacteria are pre-incubated for 20 minutes or longer before being added to the agar. This method is often more sensitive for specific chemical classes, such as short-chain aliphatic nitrosamines and azo dyes.
Dosage and Interpretation:
-
For soluble, non-cytotoxic substances, the maximum recommended concentration is 5 mg/plate or 5 μl/plate.
-
A positive result is defined by a concentration-related increase or a reproducible increase in revertant colonies in at least one strain at one or more concentrations.
-
A clear positive result indicates that the substance induces point mutations via base substitution or frameshift in the bacterial genome.
Important Limitations: -
While TG 471 is an invaluable, high-throughput screening tool, it is not exhaustive:
-
As a prokaryotic system, it cannot perfectly simulate mammalian physiology.
-
It does not provide direct information on mutagenic or carcinogenic potential in humans.
-
It may be unsuitable for highly bactericidal compounds (e.g., certain antibiotics).
-
The correlation between a positive Ames result and mammalian carcinogenicity is high but not absolute; some carcinogens act through non-genotoxic mechanisms that this test cannot detect.
Summary
The TG 471 Bacterial Reverse Mutation Test acts as the "chemical alarm" in the hierarchy of biological safety assessment. By leveraging genetically modified microorganisms, it efficiently identifies potential hazards that could alter our DNA blueprint. - Test Methods/Standards
OECD TG-471
- Test bacterial
S. typhimurium TA98
S. typhimurium A100
S. typhimurium TA1535
S. typhimuriumTA1537
E.coli WP2 uvrA -
Purpose of the Test
The objective of this study was to detect mutations in test strains (usually uses Salmonella typhimurium or Escherichia coli) caused by the test substance. Test strains are exposed to the test substance. If test substance causes mutation, test strains are able to form colonies that are visible to the human naked eyes on medium. We will infer from the growth of colonies that whether test substance is a possible carcinogen.
Click to Pay
